← Back to Clinical Trials
Recruiting NCT06986187

NCT06986187 Difficult Airway Incidence in Cardiovascular Surgery and a Prediction Model Development

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06986187
Status Recruiting
Phase
Sponsor Diskapi Teaching and Research Hospital
Condition Difficult Airway Intubation
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-06-01
Primary Completion 2027-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2025-06-01 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A difficult airway is a clinical condition that occurs when one or more of the components of difficult mask ventilation, difficult laryngoscopy, difficult endotracheal intubation, difficult supraglottic airway device (SGA) placement, and inability to intubate-oxygenate are present. Data concerning incidence of difficult airway in patients undergoing cardiovascular surgery is controversial. Unwanted hemodynamic changes that may occur in patients undergoing cardiovascular surgery, combined with hemodynamic changes caused by underlying cardiac pathologies, may also lead to a physiologically difficult airway situation. Since all these interactions, combined with the hemodynamic changes caused by difficult airway interventions, may lead to catastrophic outcomes, it is vital to predict difficult airway in this patient population.

Eligibility Criteria

Inclusion Criteria: * Undergoing cardiovascular surgery * ASA I-IV physical status * Over 18 years of age Exclusion Criteria: * Known difficult airway * Head-neck and upper airway pathology * Patients at risk of aspiration

Contact & Investigator

Central Contact

Dilek Unal, Prof.

✉ dilekunalmd@gmail.com

📞 +90 533 695 78 55

Principal Investigator

Dilek Unal, Prof.

PRINCIPAL INVESTIGATOR

Ankara Etlik City Hospital

Frequently Asked Questions

Who can join the NCT06986187 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Difficult Airway Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06986187 currently recruiting?

Yes, NCT06986187 is actively recruiting participants. Contact the research team at dilekunalmd@gmail.com for enrollment information.

Where is the NCT06986187 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06986187 clinical trial?

NCT06986187 is sponsored by Diskapi Teaching and Research Hospital. The principal investigator is Dilek Unal, Prof. at Ankara Etlik City Hospital. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology